Literature DB >> 15689447

CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms.

E Scala1, F Ariani, F Mari, R Caselli, C Pescucci, I Longo, I Meloni, D Giachino, M Bruttini, G Hayek, M Zappella, A Renieri.   

Abstract

BACKGROUND: Rett syndrome is a severe neurodevelopmental disorder, almost exclusively affecting females and characterised by a wide spectrum of clinical manifestations. Both the classic form and preserved speech variant of Rett syndrome are due to mutations in the MECP2 gene. Several other variants of Rett syndrome have been described. In 1985, Hanefeld described a variant with the early appearance of convulsions. In this variant, the normal perinatal period is soon followed by the appearance of seizures, usually infantile spasms. We have observed two patients with signs of Rett syndrome showing acquired microcephaly and stereotypic midline hand movements. The disease started with generalised convulsions and myoclonic fits at 1.5 months in the first patient and with spasms at 10 days in the other, suggesting a diagnosis of the Hanefeld variant. In these patients, MECP2 point mutations and gross rearrangements were excluded by denaturing high performance liquid chromatography and real time quantitative PCR. The ARX and CDKL5 genes have been associated with West syndrome (infantile spasms, hypsarrhythmia, and mental retardation).
METHODS: Based on the clinical overlap between the Hanefeld variant and West syndrome, we analysed ARX and CDKL5 in the two girls.
RESULTS: We found frameshift deletions in CDKL5 in both patients; one in exon 5 (c.163_166delGAAA) and the other in exon 18 (c.2635_2636delCT). CDKL5 was then analysed in 19 classic Rett and 15 preserved speech variant patients, all MECP2 negative, but no mutations were found.
CONCLUSION: Our results show that CDKL5 is responsible for a rare variant of Rett syndrome characterised by early development of convulsions, usually of the spasm type.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15689447      PMCID: PMC1735977          DOI: 10.1136/jmg.2004.026237

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  28 in total

1.  ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation.

Authors:  Thierry Bienvenu; Karine Poirier; Gaelle Friocourt; Nadia Bahi; Delphine Beaumont; Fabien Fauchereau; Lamia Ben Jeema; Ramzi Zemni; Marie-Claude Vinet; Fiona Francis; Philippe Couvert; Marie Gomot; Claude Moraine; Hans van Bokhoven; Vera Kalscheuer; Suzanne Frints; Josef Gecz; Kanae Ohzaki; Habiba Chaabouni; Jean-Pierre Fryns; Vincent Desportes; Cherif Beldjord; Jamel Chelly
Journal:  Hum Mol Genet       Date:  2002-04-15       Impact factor: 6.150

Review 2.  Rett syndrome and MeCP2: linking epigenetics and neuronal function.

Authors:  Mona D Shahbazian; Huda Y Zoghbi
Journal:  Am J Hum Genet       Date:  2002-11-19       Impact factor: 11.025

3.  Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy.

Authors:  Petter Strømme; Marie E Mangelsdorf; Marie A Shaw; Karen M Lower; Suzanne M E Lewis; Helene Bruyere; Viggo Lütcherath; Agi K Gedeon; Robyn H Wallace; Ingrid E Scheffer; Gillian Turner; Michael Partington; Suzanna G M Frints; Jean-Pierre Fryns; Grant R Sutherland; John C Mulley; Jozef Gécz
Journal:  Nat Genet       Date:  2002-03-11       Impact factor: 38.330

4.  Preserved speech variant is allelic of classic Rett syndrome.

Authors:  C De Bona; M Zappella; G Hayek; I Meloni; F Vitelli; M Bruttini; R Cusano; P Loffredo; I Longo; A Renieri
Journal:  Eur J Hum Genet       Date:  2000-05       Impact factor: 4.246

5.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.

Authors:  R E Amir; I B Van den Veyver; M Wan; C Q Tran; U Francke; H Y Zoghbi
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

6.  Mutation analysis of the methyl-CpG-binding protein 2 gene (MECP2) in Rett patients with preserved speech.

Authors:  Y Yamashita; I Kondo; T Fukuda; R Morishima; A Kusaga; R Iwanaga; T Matsuishi
Journal:  Brain Dev       Date:  2001-12       Impact factor: 1.961

7.  Study of MECP2 gene in Rett syndrome variants and autistic girls.

Authors:  Michele Zappella; Ilaria Meloni; Ilaria Longo; Roberto Canitano; Giuseppe Hayek; Lucia Rosaia; Francesca Mari; Alessandra Renieri
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-05-15       Impact factor: 3.568

8.  Characterization of two unusual RS1 gene deletions segregating in Danish retinoschisis families.

Authors:  L Huopaniemi; H Tyynismaa; A Rantala; T Rosenberg; T Alitalo
Journal:  Hum Mutat       Date:  2000-10       Impact factor: 4.878

9.  Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation.

Authors:  Vera M Kalscheuer; Jiong Tao; Andrew Donnelly; Georgina Hollway; Eberhard Schwinger; Sabine Kübart; Corinna Menzel; Maria Hoeltzenbein; Niels Tommerup; Helen Eyre; Michael Harbord; Eric Haan; Grant R Sutherland; Hans-Hilger Ropers; Jozef Gécz
Journal:  Am J Hum Genet       Date:  2003-05-07       Impact factor: 11.025

10.  Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms.

Authors:  I M Buyse; P Fang; K T Hoon; R E Amir; H Y Zoghbi; B B Roa
Journal:  Am J Hum Genet       Date:  2000-10-30       Impact factor: 11.043

View more
  60 in total

Review 1.  Brief report: systematic review of Rett syndrome in males.

Authors:  Brian Reichow; Annie George-Puskar; Tara Lutz; Isaac C Smith; Fred R Volkmar
Journal:  J Autism Dev Disord       Date:  2015-10

Review 2.  Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission.

Authors:  Lisa M Monteggia; Ege T Kavalali
Journal:  Biol Psychiatry       Date:  2008-12-05       Impact factor: 13.382

3.  Variation in novel exons (RACEfrags) of the MECP2 gene in Rett syndrome patients and controls.

Authors:  Periklis Makrythanasis; Philipp Kapranov; Lucia Bartoloni; Alexandre Reymond; Samuel Deutsch; Roderic Guigó; France Denoeud; Jorg Drenkow; Colette Rossier; Francesca Ariani; Valeria Capra; Laurent Excoffier; Alessandra Renieri; Thomas R Gingeras; Stylianos E Antonarakis
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

4.  Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications.

Authors:  Przemyslaw Szafranski; Sailaja Golla; Weihong Jin; Ping Fang; Patricia Hixson; Reuben Matalon; Daniel Kinney; Hans-Georg Bock; William Craigen; Janice L Smith; Weimin Bi; Ankita Patel; Sau Wai Cheung; Carlos A Bacino; Paweł Stankiewicz
Journal:  Eur J Hum Genet       Date:  2014-10-15       Impact factor: 4.246

5.  Novel mutations in cyclin-dependent kinase-like 5 (CDKL5) gene in Indian cases of Rett syndrome.

Authors:  Dhanjit Kumar Das; Bhakti Mehta; Shyla R Menon; Sarbani Raha; Vrajesh Udani
Journal:  Neuromolecular Med       Date:  2012-12-15       Impact factor: 3.843

6.  Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain.

Authors:  Joanne H Gibson; Barry Slobedman; Harikrishnan K N; Sarah L Williamson; Dimitri Minchenko; Assam El-Osta; Joshua L Stern; John Christodoulou
Journal:  BMC Neurosci       Date:  2010-04-26       Impact factor: 3.288

Review 7.  WONOEP appraisal: new genetic approaches to study epilepsy.

Authors:  Elsa Rossignol; Katja Kobow; Michele Simonato; Jeffrey A Loeb; Thierry Grisar; Krista L Gilby; Jonathan Vinet; Shilpa D Kadam; Albert J Becker
Journal:  Epilepsia       Date:  2014-06-25       Impact factor: 5.864

8.  Palmitoylation-dependent CDKL5-PSD-95 interaction regulates synaptic targeting of CDKL5 and dendritic spine development.

Authors:  Yong-Chuan Zhu; Dan Li; Lu Wang; Bin Lu; Jing Zheng; Shi-Lin Zhao; Rong Zeng; Zhi-Qi Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

9.  CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail.

Authors:  Laura Rusconi; Lisa Salvatoni; Laura Giudici; Ilaria Bertani; Charlotte Kilstrup-Nielsen; Vania Broccoli; Nicoletta Landsberger
Journal:  J Biol Chem       Date:  2008-08-13       Impact factor: 5.157

Review 10.  The role of epilepsy and epileptiform EEGs in autism spectrum disorders.

Authors:  Sarah J Spence; Mark T Schneider
Journal:  Pediatr Res       Date:  2009-06       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.